 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Section 1: Fundamentals of Option 1 (ICH Q3C(R9))

Slide 2: Concept Simplified (60 sec)

The Equation (Q3C, Section 5)

Section 2: Practical Application, Risks, & Compliance

Slide 4: Practical Application (60 sec)

Common Misconceptions

Slide 3: Case Study with Characters & Dialogue (90 sec)

Section 3: Auditing and Quality Assurance

10-Point Audit / Inspection Checklist (Option 1)

 10 - Point Audit / Inspection Checklist (Option 1)

Section 4: Quizzes

Slide 5: Knowledge Check + Takeaways (45 sec)

Part A — Quiz (5 Scenario-Based MCQs)

Decision Point / Compliance Dilemma

Risk Indicators (Warning Signs)

Do ✓ / Avoid ✗

Section 5: Survey and Reflection

Part B — Reflection

Welcome to "Implementing Option 1 Concentration Limits in ICH Q3C(R9)," the definitive online course designed for pharmaceutical quality assurance, quality control, and regulatory affairs professionals. Navigating the complexities of residual solvent limits is critical for ensuring patient safety and maintaining strict regulatory compliance.

Welcome to "Implementing Option 1 Concentration Limits in ICH Q3C(R9)," the definitive online course designed for pharmaceutical quality assurance, quality control, and regulatory affairs professionals. Navigating the complexities of residual solvent limits is critical for ensuring patient safety and maintaining strict regulatory compliance. This comprehensive course demystifies the Option 1 concentration-limits approach outlined in the ICH Q3C(R9) guidelines.

Throughout this training, you will explore the fundamental concepts of Option 1, including Permitted Daily Exposure (PDE), concentration limits in ppm, and the standard 10 g/day daily-dose assumption. We will break down the underlying mathematical equations, demonstrating how to convert daily mass limits into concentration limits seamlessly and accurately.

Beyond the theory, this course emphasizes practical, real-world application. You will learn how to correctly apply the Option 1 workflow across various drug substances and excipients, implement best practices for compliance, and navigate the "any proportion" allowance. Through engaging case studies, character dialogues, and scenario-based quizzes, you will develop the skills to make rigorous, risk-based compliance decisions, identify common misconceptions, and differentiate between compliant and non-compliant practices.

Finally, you will master auditing and quality assurance techniques with our exclusive 10-Point Audit and Inspection Checklist. By the end of this course, you will be fully equipped to assess supplier Certificates of Analysis (CoA), ensure dossier readiness, and drive continuous quality improvement within your organization. Enroll today to safeguard your pharmaceutical products and streamline your compliance workflows!

131. Implementing Option 1 Concentration Limits in ICH Q3C(R9)

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>Ensuring patient safety and maintaining strict regulatory compliance require the rigorous control of residual solvents in pharmaceutical manufacturing. The ICH Q3C(R9) guideline establishes a globally recognized framework for this critical task, with the Option 1 concentration-limits approach serving as a foundational methodology for defining acceptable solvent thresholds. This course delivers a comprehensive examination of the Option 1 framework, detailing the underlying mathematical principles used to convert a Permitted Daily Exposure (PDE) into a precise concentration limit. By exploring key regulatory inputs—including Class 2 solvent classifications and the standard 10 g/day maximum daily-dose assumption—professionals will understand how this approach universally caps residual solvent concentrations. Mastering these fundamentals allows formulation and manufacturing teams to utilize components in any proportion without the burden of complex, batch-specific calculations, provided the daily dose threshold is strictly observed.</p>

<p>Designed specifically for professionals across Quality Assurance, Quality Control, Regulatory Affairs, and Manufacturing, this curriculum bridges the gap between theoretical guidelines and practical, day-to-day application. Participants will navigate the correct workflows for applying Option 1 to incoming drug substances and excipients, differentiate compliant practices from common industry misconceptions, and evaluate complex batch-disposition dilemmas through realistic case studies. Furthermore, the program equips auditing and validation personnel with a robust 10-point inspection checklist to systematically assess supplier Certificates of Analysis (CoA) and internal analytical data. Through scenario-based assessments and strategic risk evaluations, stakeholders will refine the critical decision-making skills necessary to justify Module 3 specifications, maintain continuous inspection readiness, and confidently disposition materials in alignment with ICH Q3C(R9) mandates.</p>
        </div>
    </div>
</div>
